COPPER-A

The COPPER-A Trial: The Occlusion Perfusion Catheter for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis – Above the Knee

Objective

The purpose of this research study is to determine if the use of a catheter for the delivery of paclitaxel will prevent re-narrowing of a blockage to be treated in the leg.   

Patients that have a blockage in the artery of their legs are being asked to participate in this study. Participants will receive a procedure to prevent re-narrowing of the blockage in the leg. A drug will be delivered to the location of the blockage that will be opened up by the physician. A catheter, which is a small tube, will be used to deliver the drug, and the drug is called paclitaxel.

Principal Investigator(s)
Jon Robken

Clinical Trial Categories

  • Cardiac Research
Sponsor(s)
The Horizons International Peripheral Group, LLC
Contact
Genesis Research at 563-421-3941

Location

  • Medical Center, East Rusholme Street
    1227 East Rusholme Street
    Davenport, IA 52803
    Main: 563-421-1000

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email